Kantonsspital St.Gallen

Amgen Efavaleukin Alfa

Annika Eckhold, Claudia Krieger Grübel & Stephan Brand

abstract A Phase 2, Multicenter, Dose-finding, Double blinded, Pla-cebo- Controlled Study to Evaluate the Safety and Effi-cacy of Efavaleukin Alfa Induc-tion Therapy in Patients with Mederatly to Severely UC
type of project clinical studies
status ongoing - recruiting phase
start of project 2022
end of project 2023
study design Double blinded, 3 arms
responsible person Prof. Dr. Stephan Brand